International Conference on Critical Care Pharmacology and Therapeutics - (ICCCPT-26)


21st - 22nd December, 2026 | Los Angeles, USA

Multi-format (In-person/Virtual)

Registration Options

Explore conference registration categories designed for every mode of participation.

Important Dates

Pre-registration Deadline

21st November, 2026

Paper Submission Deadline

26th November, 2026

Last Date Of Registration

6th December, 2026

Date Of Conference

21st - 22nd December, 2026

Downloads

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3 SDG 3 — Good Health and Well-being
SDG 4 SDG 4 — Quality Education
SDG 9 SDG 9 — Industry, Innovation and Infrastructure
SDG 16 SDG 16 — Peace, Justice and Strong Institutions
SDG 17 SDG 17 — Partnerships for the Goals
Explore

All Session Tracks

Track 01
Advancements in Critical Care Pharmacology

This session will explore the latest advancements in pharmacological interventions for critically ill patients. Emphasis will be placed on novel drug therapies and their implications for patient outcomes in intensive care settings.

Track 02
Therapeutic Strategies in Critical Illness

This track will focus on innovative therapeutic strategies tailored for patients experiencing critical illness. Discussions will include evidence-based practices and emerging therapies that enhance recovery in intensive care.

Track 03
Clinical Pharmacology in Intensive Care Units

This session aims to delve into the role of clinical pharmacology within intensive care units. Participants will examine pharmacokinetics, pharmacodynamics, and the challenges of drug management in critically ill patients.

Track 04
Drug Development for Critical Care Applications

This track will highlight the unique challenges and opportunities in drug development specifically for critical care applications. Presentations will cover the regulatory landscape and innovative research methodologies in this field.

Track 05
Pharmacological Research in Critical Care Settings

This session will showcase current research initiatives focusing on pharmacological interventions in critical care. Attendees will gain insights into ongoing studies and their potential impact on clinical practice.

Track 06
Critical Care Nursing and Pharmacotherapy

This track will address the intersection of critical care nursing and pharmacotherapy. Discussions will focus on the nurse's role in medication management and the implications for patient safety and care.

Track 07
Drug Safety and Risk Management in Critical Care

This session will explore drug safety protocols and risk management strategies in critical care environments. Participants will discuss adverse drug reactions and the importance of monitoring in vulnerable patient populations.

Track 08
Ethical Considerations in Critical Care Pharmacology

This track will examine the ethical dilemmas faced in critical care pharmacology. Topics will include informed consent, end-of-life decisions, and the ethical implications of experimental therapies.

Track 09
Personalized Medicine in Critical Care

This session will focus on the role of personalized medicine in the management of critically ill patients. Discussions will include genetic factors influencing drug response and the potential for tailored therapeutic approaches.

Track 10
Innovations in Drug Delivery Systems for Critical Care

This track will highlight innovations in drug delivery systems designed for critical care applications. Participants will explore advancements that enhance the efficacy and safety of pharmacological treatments.

Track 11
Interdisciplinary Approaches to Critical Care Pharmacology

This session will promote interdisciplinary collaboration in the field of critical care pharmacology. Attendees will discuss the integration of various healthcare professionals in optimizing pharmacotherapy for critically ill patients.